Table of contents
- Antitrust
- Mergers
- Private actions
- Sector regulators
- Upcoming dates
Article summary
A round-up of UK competition law developments including (amongst other things) (1) the CMA’s decision to open a Chapter II investigation into the conduct of ESS, and (2) UK enforceability of Aspen’s commitments relating to cancer drug.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial